Arrowhead Research | ARWR - EPS Earnings Per Share


Arrowhead Research reported $0.22 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q2 Mar/2026 -1.04 2.75 May/07
FY2026Q1 Dec/2025 0.22 0.04 -1.39 Feb/05
FY2025Q4 Sep/2025 -0.11 -0.23 -1.36 Nov/25
FY2025Q3 Jun/2025 -1.26 -0.86 -1.38 Aug/07
FY2025Q2 Mar/2025 2.75 -0.11 -1.02 May/12




Eps Change Date
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
Heron Therapeutics USD -0.02 0.02 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Ligand Pharmaceuticals USD 2.02 1.07 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xencor USD -0.09 0.01 Dec/2025